News & Research

Researchers ID protein “signature” in severe COVID-19 cases

Data reveal risks of allergic reaction after COVID-19 mRNA vaccines

Research yields insights into antibody immunity after SARS-CoV-2 infection

No benefit found for early anticlotting therapy in severe COVID-19

Current COVID-19 vaccines are safe for those with allergies

Three studies examine coronavirus, antibodies during pregnancy

Study sheds light on how severe COVID-19 pneumonia develops

Neutralizing antibodies protect against severe COVID-19

Success depends on delivery speed, pandemic severity, public

Antibody development quality may predict COVID-19 outcomes

Elevated levels of a blood clotting factor linked to worse outcomes in severe COVID-19

Study finds no relationship between blood type and severity of COVID-19